Status:
COMPLETED
Zinc Therapy in HIV Infected Individuals Who Abuse Drugs
Lead Sponsor:
Florida International University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV Infections
Substance-Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse dr...
Detailed Description
Low levels of zinc are associated with an increased risk of HIV-related death and opportunistic infections in HIV infected individuals. Drug users are especially susceptible to zinc deficiency. The pu...
Eligibility Criteria
Inclusion
- HIV infected
- Drug User
- Blood zinc level greater than 0.35 mcg/mL and less than 0.75mcg/ml
Exclusion
- Currently participating in an another clinical trial
- Blood selenium level less than 85 mcg/L
- Pregnant or intends to become pregnant
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
231 Patients enrolled
Trial Details
Trial ID
NCT00149552
Start Date
June 1 2001
End Date
January 1 2007
Last Update
March 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Camillus House
Miami, Florida, United States, 33132